세계의 신장결석 시장(2022-2026년)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 신장결석 시장 규모는 2022-2026년간 4억 1,609만 달러 성장하고, 예측기간 중 6.69%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.

시장 성장의 원동력은 디지털 플렉서블 요관경의 인기와 요로 결석증 발생률 상승입니다.

세계 신장결석(Kidney Stones) 시장의 전체적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 분석 정보를 전해드립니다.

목차

개요

시장 구도

• 시장 생태계
• 밸류체인 분석

시장 규모

• 시장의 정의
• 시장 부문 분석
• 시장 규모(2021년)
• 시장 전망 : 예측(2021-2026년)

Five Forces 분석

• 바이어의 교섭력
• 공급 기업의 교섭력
• 신규 진출업체의 위협
• 대체품의 위협
• 경쟁사의 위협
• 시장 현황

시장 세분화 : 유형별

• 시장 세분화
• 유형별 비교
• 타이아자이드 이뇨제 : 시장 규모와 예측(2021-2026년)
• 진통제 : 시장 규모와 예측(2021-2026년)
• 항생제 : 시장 규모와 예측(2021-2026년)
• 기타 : 시장 규모와 예측(2021-2026년)
• 유형별 시장 기회

고객 상황

지역별 상황

• 지역별 세분화
• 지역별 비교
• 북미 : 시장 규모와 예측(2021-2026년)
• 유럽 : 시장 규모와 예측(2021-2026년)
• 아시아 : 시장 규모와 예측(2021-2026년)
• 기타 지역 : 시장 규모와 예측(2021-2026년)
• 주요 국가
• 지역 상황별 시장 기회
• 시장 성장 촉진요인
• 시장이 해결해야 할 과제
• 시장 동향

벤더 구도

• 혼란 상황

벤더 분석

• 대상 벤더
• 벤더의 시장 포지셔닝
• Aristo Pharma GmbH
• Bausch Health Companies Inc.
• Bayer AG
• Cipla Inc.
• Dr. Reddys Laboratories Ltd.
• Emcure Pharmaceuticals Ltd.
• GlaxoSmithKline Plc
• Intas Pharmaceuticals Ltd.
• Macleods Pharmaceuticals Ltd.
• Pfizer Inc.

부록

Technavio has been monitoring the kidney stones market and it is poised to grow by $ 416.09 mn during 2022-2026, progressing at a CAGR of 6.69% during the forecast period. Our report on the kidney stones market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing popularity of digital flexible ureteroscopes and rising incidence of urolithiasis. In addition, the growing popularity of digital flexible ureteroscopes is anticipated to boost the growth of the market as well.

The kidney stones market analysis includes the type segment and geographic landscape.

Technavio's kidney stones market is segmented as below:

By Type

• Thiazide diuretic
• Pain relievers
• Antibiotics
• Others

By Geographical Landscape

• North America
• Europe
• Asia
• ROW

This study identifies the increasing prevalence of kidney stone diseaseas one of the prime reasons driving the kidney stones market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on kidney stones market covers the following areas:

• Kidney stones market sizing
• Kidney stones market forecast
• Kidney stones market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading kidney stones market vendors that include Aristo Pharma GmbH, Bausch Health Companies Inc., Bayer AG, Cipla Inc., Dr. Reddys Laboratories Ltd., Emcure Pharmaceuticals Ltd., GlaxoSmithKline Plc, Intas Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., and Pfizer Inc. Also, the kidney stones market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

• Executive Summary
  • Market Overview
• Market Landscape
  • Market ecosystem
  • Value chain analysis
• Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2021
  • Market outlook: Forecast for 2021 - 2026
• Five Forces Analysis
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
• Market Segmentation by Type
  • Market segments
  • Comparison by Type
  • Thiazide diuretic - Market size and forecast 2021-2026
  • Pain relievers - Market size and forecast 2021-2026
  • Antibiotics - Market size and forecast 2021-2026
  • Others - Market size and forecast 2021-2026
  • Market opportunity by Type
• Customer landscape
• Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2021-2026
  • Europe - Market size and forecast 2021-2026
  • Asia - Market size and forecast 2021-2026
  • ROW - Market size and forecast 2021-2026
  • Key leading countries
  • Market opportunity By Geographical Landscape
  • Market drivers
  • Market challenges
  • Market trends
• Vendor Landscape
  • Landscape disruption
• Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Aristo Pharma GmbH
  • Bausch Health Companies Inc.
  • Bayer AG
  • Cipla Inc.
  • Dr. Reddys Laboratories Ltd.
  • Emcure Pharmaceuticals Ltd.
  • GlaxoSmithKline Plc
  • Intas Pharmaceuticals Ltd.
  • Macleods Pharmaceuticals Ltd.
  • Pfizer Inc.
• Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibits

• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global - Market size and forecast 2021 - 2026 ($ million)
• 13: Global market: Year-over-year growth 2021 - 2026 (%)
• 14: Five forces analysis 2021 & 2026
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition - Five forces 2021
• 21: Type - Market share 2021-2026 (%)
• 22: Comparison by Type
• 23: Thiazide diuretic - Market size and forecast 2021-2026 ($ million)
• 24: Thiazide diuretic - Year-over-year growth 2021-2026 (%)
• 25: Pain relievers - Market size and forecast 2021-2026 ($ million)
• 26: Pain relievers - Year-over-year growth 2021-2026 (%)
• 27: Antibiotics - Market size and forecast 2021-2026 ($ million)
• 28: Antibiotics - Year-over-year growth 2021-2026 (%)
• 29: Others - Market size and forecast 2021-2026 ($ million)
• 30: Others - Year-over-year growth 2021-2026 (%)
• 31: Market opportunity by Type
• 32: Customer landscape
• 33: Market share By Geographical Landscape 2021-2026 (%)
• 34: Geographic comparison
• 35: North America - Market size and forecast 2021-2026 ($ million)
• 36: North America - Year-over-year growth 2021-2026 (%)
• 37: Europe - Market size and forecast 2021-2026 ($ million)
• 38: Europe - Year-over-year growth 2021-2026 (%)
• 39: Asia - Market size and forecast 2021-2026 ($ million)
• 40: Asia - Year-over-year growth 2021-2026 (%)
• 41: ROW - Market size and forecast 2021-2026 ($ million)
• 42: ROW - Year-over-year growth 2021-2026 (%)
• 43: Key leading countries
• 44: Market opportunity By Geographical Landscape ($ million)
• 45: Impact of drivers and challenges
• 46: Vendor landscape
• 47: Landscape disruption
• 48: Industry risks
• 49: Vendors covered
• 50: Market positioning of vendors
• 51: Aristo Pharma GmbH - Overview
• 52: Aristo Pharma GmbH - Product and service
• 53: Aristo Pharma GmbH - Key offerings
• 54: Aristo Pharma GmbH - Key customers
• 55: Aristo Pharma GmbH - Segment focus
• 56: Bausch Health Companies Inc. - Overview
• 57: Bausch Health Companies Inc. - Business segments
• 58: Bausch Health Companies Inc. - Key offerings
• 59: Bausch Health Companies Inc. - Key customers
• 60: Bausch Health Companies Inc. - Segment focus
• 61: Bayer AG - Overview
• 62: Bayer AG - Business segments
• 63: Bayer AG - Key offerings
• 64: Bayer AG - Key customers
• 65: Bayer AG - Segment focus
• 66: Cipla Inc. - Overview
• 67: Cipla Inc. - Business segments
• 68: Cipla Inc. - Key offerings
• 69: Cipla Inc. - Key customers
• 70: Cipla Inc. - Segment focus
• 71: Dr. Reddys Laboratories Ltd. - Overview
• 72: Dr. Reddys Laboratories Ltd. - Business segments
• 73: Dr. Reddys Laboratories Ltd. - Key offerings
• 74: Dr. Reddys Laboratories Ltd. - Key customers
• 75: Dr. Reddys Laboratories Ltd. - Segment focus
• 76: Emcure Pharmaceuticals Ltd. - Overview
• 77: Emcure Pharmaceuticals Ltd. - Product and service
• 78: Emcure Pharmaceuticals Ltd. - Key offerings
• 79: Emcure Pharmaceuticals Ltd. - Key customers
• 80: Emcure Pharmaceuticals Ltd. - Segment focus
• 81: GlaxoSmithKline Plc - Overview
• 82: GlaxoSmithKline Plc - Business segments
• 83: GlaxoSmithKline Plc - Key offerings
• 84: GlaxoSmithKline Plc - Key customers
• 85: GlaxoSmithKline Plc - Segment focus
• 86: Intas Pharmaceuticals Ltd. - Overview
• 87: Intas Pharmaceuticals Ltd. - Product and service
• 88: Intas Pharmaceuticals Ltd. - Key offerings
• 89: Intas Pharmaceuticals Ltd. - Key customers
• 90: Intas Pharmaceuticals Ltd. - Segment focus
• 91: Macleods Pharmaceuticals Ltd. - Overview
• 92: Macleods Pharmaceuticals Ltd. - Product and service
• 93: Macleods Pharmaceuticals Ltd. - Key offerings
• 94: Macleods Pharmaceuticals Ltd. - Key customers
• 95: Macleods Pharmaceuticals Ltd. - Segment focus
• 96: Pfizer Inc. - Overview
• 97: Pfizer Inc. - Business segments
• 98: Pfizer Inc. - Key offerings
• 99: Pfizer Inc. - Key customers
• 100: Pfizer Inc. - Segment focus
• 101: Currency conversion rates for US$
• 102: Research Methodology
• 103: Validation techniques employed for market sizing
• 104: Information sources
• 105: List of abbreviations